Nervgen Pharma NGEN
NASDAQ NGEN
$1.93 +0.01 (+0.78%)
As of: Sep 30, 2026 · 3:47 PM EDT

Nervgen Pharma (NGEN) Debt Ratio (2024 - 2025)

Updated

Nervgen Pharma's Debt Ratio was 0.00 in the quarter ended Dec 31, 2025, down 92.8% from 0.00 a year earlier.

Analysis

Nervgen Pharma (NGEN) Debt Ratio (2024 - 2025) Analysis & Trends

  • In earlier years, Debt Ratio was 0.00 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.24
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.52
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.42
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.31
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.00
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.60
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Nervgen Pharma 152.93 Mn 152.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Dec 31, 2024 0.00
API Access

Nervgen Pharma Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=NGEN&period=max&api_key=YOUR_API_KEY